1,2,3,4-tetrahydroquinoline has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Camacho, ME; Campos, JM; Carrión, MD; Fernández-Sáez, N; Rubio-Ruiz, B; Unciti-Broceta, A | 1 |
1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Colonic Neoplasms
Article | Year |
---|---|
Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Halogenation; HCT116 Cells; Humans; MCF-7 Cells; Purines; Quinolines; Structure-Activity Relationship | 2019 |